BWX Technologies, Inc. (BWXT) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed

Updated Aug 13, 2026Q1 FY2026 reviewed

BWXT manufactures nuclear reactor components and fuel for naval and commercial nuclear power markets tied to AI-driven electricity demand.

Backlog $8.4B

Q2 2026 backlog up 40% year over year.

Book-to-bill 1.7x

Trailing-twelve-month demand intake well above revenue.

Commercial +72% YoY

Organic growth +33% in Q2 2026.

Commercial margin ~13%

FY2026 guide lowered from ~14% for capacity investment.

The Buildout Takeaway

The company is concentrating on national security nuclear and commercial nuclear power after agreeing to sell its medical business. The main open question is whether the expected new-build reactor orders arrive before the capacity commitments start to pressure margins.

Analyst coverage

16 analysts·11 Buy4 Hold1 Sell

Coverage is thin — only 2 price estimates, so no target is shown

Management guidance

Revenue ~$3.8B, high-teens growth · Adjusted EBITDA $662–672M · Non-GAAP EPS $4.70–4.80 · Free cash flow $345–360M · Commercial revenue growth ~45% · Government EBITDA margin ~20.5%

Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.

Our View

The Verdict

BWXT manufactures precision naval nuclear components, reactors, and fuel for the U.S. Navy nuclear propulsion program, and designs and builds commercial nuclear equipment including steam generators, pressure vessels, and reactor components. It also produces advanced nuclear fuels and provides nuclear services. The company matters to the AI buildout because it sits upstream of the reactors and fuel that could supply clean baseload power to data centers, even though it does not sell AI infrastructure directly.

Market Cap	—
Revenue (TTM)	$3.4B
Revenue Growth	+21.4%
EBITDA Margin (TTM)	13.8%

Net Debt	$1.5B
Earnings Beats	7 of 7
P/E (TTM)	—
EV/EBITDA (TTM)	—

What We Like

Backlog of $8.4B at Q2 2026, up 40% year over year, with trailing book-to-bill of 1.7x.
U.S. Government concentration fell from 76% in FY2024 to 68% in FY2025 as Commercial Operations scaled.
Commercial Operations revenue grew 72% total and 33% organic year over year in Q2 2026.
Management expects at least one new-build nuclear equipment order before year-end 2026 and a U.S. large-component final investment decision in the coming months.
Naval anchor includes $1.4B in contracts announced May 2026 and a Navy plan for 2 Virginia-class and 1 Columbia-class submarines per year.

What We’re Watching

Whether the year-end new-build order materializes or slips as utilities wait for government SPV structures to finalize.
Commercial margin dilution: FY2026 margin guided down to ~13% from ~14% for capacity investment.
Government Operations revenue growth guided down to high single digits, though management attributes this to favorable cost-performance accounting.
PCG integration and filling its estimated ~50% available capacity are a nearer-term execution test.

Bottom Line

The thesis is intact and strengthening on demand evidence, but it carries a timing lean because BWXT is deliberately expanding capacity and compressing Commercial margin before a confirmed year-end order. The open question is whether the new-build equipment order arrives before year-end 2026.

Next upThey test whether the first large reactor order and the U.S. large-component capacity decision support the capacity buildout.

Last Quarter — Q1 FY2026

Earnings Beat

Q2 2026 revenue was $902 million, up 18% year over year and 9% organic. Adjusted EBITDA was $155 million, up 7%. Backlog ended at $8.4 billion, up 40% year over year, and free cash flow was $115 million.

Metric	Q1 FY2026	Q4 FY2025	Q1 FY2025	YoY
Revenue	$861M	$886M	$682M	+26.2%
Gross margin	23.0%	21.0%	24.2%	-120bps
EBITDA	$115M	$101M	$120M	−4.6%
EPS	$0.99	$1.01	$0.82	+20.8%
Backlog	$8.4B	$8.7B	$6.0B	+40%

Demand for nuclear solutions continues to build across the national security and global commercial power markets. We are benefiting from that demand today and believe the industry is in the early stages of a multi-decade super cycle of growth.— Rex Geveden, CEO, August 3, 2026

Management tone: Management shifted from the prior quarter's "we are not betting on a horse" to a tighter focus, saying "we can't shoot at everything that moves." The Q2 call tone was direct about the medical divestiture, the mPower history, and EPC risk, while management declined to quantify Janus economics and the organic/inorganic EBITDA split.

Management Guidance

Full-year 2026 guidance was raised: revenue ~$3.8 billion, high-teens growth; adjusted EBITDA $662–672 million; non-GAAP EPS $4.70–4.80; free cash flow $345–360 million. The Government Operations revenue growth guide was lowered to high single digits because cost underruns reduce reported revenue, while its EBITDA margin guide was raised to ~20.5%. Commercial Operations revenue growth was raised to ~45%, while its EBITDA margin guide was lowered to ~13%.

Business Trajectory

Trajectory

Revenue moved from $682.3M in Q1 FY2025 to $861.1M in Q1 FY2026 and then to $902M in Q2 2026 as reported by the company, with Q2 growth of 18% year over year after 26% in Q1. On the financial facts basis, gross margin compressed from 24.2% to 23.0% over the same Q1 comparison, while EBITDA margin fell from 17.7% to 13.3%, reflecting the Commercial mix shift toward Kinectrics services and capacity investment. TTM revenue was $3,377.2M and TTM EBITDA was $466.3M, or 13.8%.

Revenue & Margin Trajectory

Gross margin as reported.

Share Price — 12 Months

52-week range $157–$238.

Share Price — 12 Months

52-week range $157–$238.

The Numbers

The Model

The model projects FY+1 revenue of $3,821M and EBITDA of $653M, a 17.1% margin, close to the company's own ~$3.8B revenue guide. FY+2 revenue is $4,420M with EBITDA of $774M, a 17.5% margin, driven by the expected commercial nuclear order wave, PCG contribution, and capacity expansion. These are revenue and EBITDA projections only.

Revenue & EBITDA Projections

Solid bars are reported actuals; outlined bars are model projections — not company guidance.

Metric	FY2025	Next FY (E)	Following FY (E)
Revenue	$3.2B	$3.8B	$4.2B
YoY Growth	—	+18.8%	+10.5%
EBITDA	$472M	$669M	$769M
EBITDA Margin	14.8%	17.6%	18.3%

Projections are the median of 5 independent model runs. The model’s revenue sits 1.7% above analyst consensus.

What Could Go Right — and Wrong

What good looks like

At least one new-build nuclear equipment order lands before year-end 2026.
U.S. large-component manufacturing final investment decision is made in the coming months with a deepwater site.
Janus award is secured, triggering the Wyoming TRISO scale-up with Kairos.
Ford-class 4-year procurement cadence and the nuclear-powered battleship become funded.
Canada's plan for up to 10 new large reactors starts converting into long-lead component orders earlier than the early 2030s.

What could go wrong

Year-end new-build order slips as SPV structures remain unresolved into 2027.
EPC bottlenecks delay the broader nuclear build-out despite policy support.
Commercial EBITDA margin stays depressed beyond 2026 because capacity costs grow faster than orders.
Government appropriations or a major utility relationship shift unfavorably, given concentration.
PCG integration stalls, leaving the estimated ~50% available capacity unfilled.

What’s Next

Looking Ahead

The next 12 months center on capacity and order proof. BWXT expects a final investment decision on U.S. large-component manufacturing in the coming months and a credible opportunity for at least one new-build equipment order before year-end. The Janus award and centrifuge prototype are both expected this year, while HPDU construction should contribute revenue in 2H 2026.

Catalysts

In the coming monthsU.S. large-component FID — Site selection among New Jersey, Indiana, and one other option.
2H 2026HPDU construction and revenue ramp — Jonesborough plant should contribute meaningfully to Government revenue.
Before year-end 2026New-build equipment order — Credible opportunity for at least one Darlington, AP1000, or X300 order.
Expected this yearJanus award decision — Would solidify TRISO order pipeline and Wyoming scale-up.
2026Centrifuge operational prototype — Centrifuge Manufacturing Development Facility on schedule.

Numbers

Financials

Annual Summary

Metric	FY2024	FY2025	TTM	YoY
Revenue	$2.7B	$3.2B	$3.4B	+18.3%
Gross Margin	24.3%	23.0%	22.6%	125bps
EBITDA	$466M	$472M	$4.1B	+1.2%
EBITDA Margin	17.2%	14.8%	13.8%	250bps
Net Income	$282M	$329M	$345M	+16.7%
Free Cash Flow	$255M	$295M	$1.4B	—
Net Cash	—	—	—	—

Key Ratios (Trailing)

Valuation

P/E TTM—
EV/EBITDA TTM—
EV/Revenue TTM—
Price/FCF TTM—

Profitability

Gross Margin (TTM)22.6%
EBITDA Margin (TTM)13.8%
Net Margin (TTM)10.2%
ROIC10.0%
FCF Conversion70.4%
SBC / Revenue0.9%

Reference

The Company

BWXT manufactures precision naval nuclear components, reactors, and fuel for the U.S. DOE/NNSA Naval Nuclear Propulsion Program, and commercial nuclear equipment including steam generators, heat exchangers, pressure vessels, reactor components, and spent-fuel containers. It also produces advanced fuels such as TRISO and HALEU and provides nuclear services through Kinectrics. This matters because the company sits upstream of clean baseload nuclear power that AI data centers are seeking, though the AI link is indirect.

BWXT operates through Government Operations and Commercial Operations segments across U.S. sites in Virginia, Ohio, Indiana, and Tennessee and Canadian sites concentrated in Ontario and British Columbia. The company is expanding Cambridge, Ontario by 60,000 square feet and has acquired PCG to add U.S. commercial manufacturing. It also operates advanced fuel and centrifuge facilities in Lynchburg and near Oak Ridge.

Business Segments

Government Operations

FY2026 revenue growth guided to high single digits; EBITDA margin guided to ~20.5%.

Designs and manufactures precision naval nuclear components, reactors, and fuel for the U.S. DOE/NNSA Naval Nuclear Propulsion Program, plus uranium processing, special materials, and Technical Services.

Growth driver: Ford-class 4-year cadence; HPDU 2H ramp.

Commercial Operations

FY2026 revenue growth guided to ~45%; EBITDA margin guided to ~13%.

Designs and manufactures commercial steam generators, heat exchangers, pressure vessels, reactor components, fuel, and spent-fuel containers; includes Kinectrics nuclear services.

Growth driver: AP1000, X300, and Darlington SMR new-build orders.

Competitive Landscape

Management positions BWXT as a merchant supplier across reactor designs rather than tied to one technology, saying the company is not betting on a horse but on the race. It expects the Cambridge expansion to create the world's largest nuclear clean room. The source material supplied does not name BWXT's direct competitors.

Supply Chain

BWXT sits between nuclear materials and component suppliers and reactor vendors, utilities, and the U.S. Government. Its AI relevance flows through reactor orders and advanced fuel rather than direct data-center sales.